Influence of Vitamin D on Inflammatory Bowel Disease Remission

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Hillel Yaffe Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Technion, Israel Institute of Technology
Information provided by:
Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier:
NCT01121796
First received: May 10, 2010
Last updated: NA
Last verified: May 2010
History: No changes posted
  Purpose

Vitamin D has been shown to influence a multitude of systems. We intend to see whether different types of Vitamin D supplements have an effect on inflammatory bowel disease.


Condition Intervention
Inflammatory Bowel Disease
Dietary Supplement: Vitamin D
Other: Water or milk
Dietary Supplement: Vitamin D enriched milk

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double Blind (Subject, Caregiver)
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Hillel Yaffe Medical Center:

Primary Outcome Measures:
  • Inflammatory disease remission [ Time Frame: One year ] [ Designated as safety issue: No ]

Estimated Enrollment: 90
Study Start Date: June 2010
Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Active Comparator: Vitamin D Dietary Supplement: Vitamin D
Placebo Comparator: Placebo Other: Water or milk
Active Comparator: Unique vehicle for Vitamin D supplementation Dietary Supplement: Vitamin D enriched milk

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Mild to moderate inflammatory bowel disease

Exclusion Criteria:

  • Hypersensitivity to milk products
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01121796

Contacts
Contact: Zvi Fireman, MD fireman@hy.health.gov.il
Contact: Oren Atia, MD orena@hy.health.gov.il

Locations
Israel
Hillel Yaffe Medical Center Not yet recruiting
Hadera, Israel, 38100
Sponsors and Collaborators
Hillel Yaffe Medical Center
Technion, Israel Institute of Technology
  More Information

No publications provided

Responsible Party: Dr. Zvi Fireman, Director Gastroenterology Institute, Hillel Yaffe Medical Center
ClinicalTrials.gov Identifier: NCT01121796     History of Changes
Other Study ID Numbers: HY100510
Study First Received: May 10, 2010
Last Updated: May 10, 2010
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Inflammatory Bowel Diseases
Intestinal Diseases
Gastroenteritis
Gastrointestinal Diseases
Digestive System Diseases
Vitamin D
Ergocalciferols
Vitamins
Bone Density Conservation Agents
Physiological Effects of Drugs
Pharmacologic Actions
Micronutrients
Growth Substances

ClinicalTrials.gov processed this record on April 22, 2014